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Abstract 
Obstructive sleep apnoea–hypopnea syndrome (OSAHS) and multimorbidity are common in elderly patients, but 
a potential link between the two conditions remains unclear. This study aimed to assess the prevalence of OSAHS, 
chronic multimorbidity and their relation in older adults in primary care settings. A screening study was performed 
in a cross-section of 490 elderly adults (mean age 77.5 years, 51 % male) receiving home care services in Thessaly, 
central Greece. The Berlin Questionnaire was employed to assess the likelihood for OSAHS and the Epworth Sleepi-
ness Scale to assess daytime sleepiness. Multimorbidity was defined as a documented history of at least two chronic 
diseases. The prevalence of high risk for OSAHS, excessive daytime sleepiness and multimorbidity was 33.5, 11.6 and 
63.9 %, respectively. None of the study subjects had a confirmed diagnosis for OSAHS prior to this study. A marked 
dose–response association between a high pre-test likelihood for OSAHS and multimorbidity was noted in patients 
with two [adjusted odds ratio (OR) 3.13; 95 % confidence interval (CI) 1.85–5.30) and three or more (adjusted OR 4.22; 
95 % CI 2.55–6.96) chronic morbidities, independently of age, sex and smoking status. This association persisted across 
different levels for OSAHS risk in the Berlin questionnaire, was insensitive to varying definitions of multimorbidity and 
more pronounced in patients with excessive daytime sleepiness. These findings point out that primary care physicians 
who care for elderly patients who present with several, common and burdensome, chronic diseases should expect 
to find this multimorbidity often coinciding with undetected, and therefore untreated, OSAHS. Thus it is crucial to 
consider OSAHS as an important co-morbidity in older adults and systematically screen for OSAHS in primary care 
practice.
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Background
Obstructive sleep apnoea–hypopnoea syndrome 
(OSAHS) is a common disorder that affects least 2–4 % 
of the adult population (Young et al. 1993; Epstein et al. 
2009). The syndrome affects largely the older adults and 
its prevalence has been reported to exceed 30 % in those 
aged 65  years and over (Epstein et  al. 2009). Clinically, 
OSAHS is defined by the occurrence of witnessed breath-
ing (at least five events of apnoea/hypopnoea per hour 
of sleep) with associated symptoms such as persistent 
loud snoring and fatigue or excessive daytime sleepiness 
(Young et al. 2002; Epstein et al. 2009). OSAHS poses an 
important public health problem not only due to its high 
prevalence, but also because it is associated with condi-
tions that account for leading causes of morbidity and 
mortality in adults, including hypertension, metabolic 
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syndrome, cardiovascular and cerebrovascular diseases 
(Young et al. 2002; Parish et al. 2007; Dorasamy 2007).
OSAHS and chronic diseases are both commonly 
seen in primary care settings and their frequency var-
ies widely with age and gender (Karachaliou et  al. 
2007; Minas et  al. 2010; Kleisiaris et  al. 2014). Multi-
morbidity—the co-occurrence of several chronic dis-
eases in one individual—is also a common problem 
encountered in elderly patients (Fortin et  al. 2012; 
Minas et al. 2010; Søndergaard et al. 2015). However, a 
potential link between OSAHS and multimorbidity has 
not been studied extensively (Robichaud-Hallé et  al. 
2012), mainly because the syndrome often remains 
undiagnosed in primary care practice (Young et  al. 
1993; Karachaliou et al. 2007). Evidence of an associa-
tion between OSAHS and multimorbidity could serve 
as a crucial incentive for the systematic screening for 
OSAHS in primary care settings (Robichaud-Hallé 
et al. 2012).
Consequently in this study we sought to assess the risk 
of OSAHS, measure multimorbidity, and evaluate a pos-
sible epidemiological link between the two conditions in 
an elderly population in primary care settings. We also 
examined the persistence of this association in the sub-
group of subjects who presented with excessive daytime 




In this cross-sectional study we recruited older adults, 
aged 65  years and older, who were receiving home care 
services in Thessaly, central Greece. We used a conveni-
ence sample of subjects who were attending an ‘Open 
Care Community Centre for Older People’ or were reg-
istered in the ‘Help at Home’ programme (Skaperdas 
et al. 2010). These health services are directed mainly to 
rural and semirural populations and include social, nurs-
ing and medical care of older adults with a disadvantaged 
social status and/or a poor family support. We have pre-
viously reported the findings of a spirometry program to 
screen for airflow limitation in the same sample of elderly 
subjects (Kleisiaris et al. 2014).
Because we had no prior information on the preva-
lence of OSAHS or multimorbidity in the study popu-
lation, we used a conservative sample size calculation. 
We assumed the most conservative scenario of having 
to estimate prevalence proportions of 50  %. Based on 
Cochran’s formula, we initially aimed for a minimum 
sample size of 385 to allow a 5 % level of precision in the 
estimated prevalence proportions with a confidence level 
of 95 %. Because we had no prior experience in surveying 
this particular population, we inflated the sample size to 
account for a high anticipated non-response rate of 25 % 
and used a sample size estimate of 518.
Following an initial invitation by the local municipal-
ity authorities, 518 elderly adults in sixteen home care 
settings were approached by a member of the research 
team, were informed about the study and asked to partic-
ipate. Screening questionnaires were completed through 
face-to-face home interviews that lasted between 30 and 
60  min. Data were collected during a 6-month period 
(January–June 2010).
Screening questionnaires and definitions
We employed the Berlin Questionnaire to screen for 
OSAHS (Netzer et  al. 1999), which has been translated 
and shown to be a sensitive and predictive screening 
tool for OSAHS in primary healthcare settings in Greece 
(Bouloukaki et al. 2013). In brief, the questionnaire evalu-
ates snoring behaviour and witnessed apnoeas during 
sleep (“Background” section), tiredness or fatigue after 
sleep (“Methods” section) and history of hypertension 
and obesity (“Results” section). A high pre-test likelihood 
(“high risk”) for OSAHS is assigned to patients whose 
responses qualify as high risk in at least two sections of 
the questionnaire.
As excessive daytime sleepiness (EDS) is a common 
complaint in OSAHS patients, we used the Epworth 
Sleepiness Scale (ESS) to assess daytime sleepiness (Johns 
1991). ESS quantifies the level of daytime sleepiness by 
having individuals to self-rate the likelihood of dozing 
during eight different daytime situations and by produc-
ing a summary score that ranges from 0 to 24. A score 
greater than 10 is indicative of EDS (Johns 1991). We 
used the validated Greek version of the scale (Tsara et al. 
2004).
To record morbidity data, we checked for confirmed 
diagnoses of chronic diseases in the medical records of 
each study subject and also assessed current medications. 
We sought to include common and burdensome chronic 
diseases based on the main causes of disease burden in 
primary healthcare in Greece (Minas et  al. 2010). We 
defined multimorbidity as a documented history of at 
least two chronic diseases (Barnett et al. 2012; Ornstein 
et al. 2013).
Demographic data were also recorded and included 
gender, age, weight, height and smoking status. Study 
subjects with an active smoking status of more than 30 
packs per year were considered current smokers and 
those with no history of active smoking were recorded as 
non-smokers. Smokers were classified as former smokers 
if they had quit smoking for at least 12 months. Obesity 
was defined as a body mass index (BMI) ≥30 kg/m2.
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Statistical analysis
Reliabilities of the Berlin questionnaire and the ESS were 
assessed using Cronbach’s coefficient. 95  % confidence 
intervals (CI) for proportions were calculated using Wil-
son’s Score method. The strength and direction of asso-
ciations between a high pre-test likelihood for OSAHS 
and the various chronic morbidities were presented using 
odds ratios (OR) and corresponding CI as calculated by 
binary logistic regression. The Extended Mantel-Haenz-
sel Chi square test for linear trend was used to assess the 
dose–response relationship between the level of multi-
morbidity and a high pre-test likelihood for OSAHS.
To adjust for potential confounding effects by gender, 
age and smoking status, multiple logistic regression anal-
ysis was performed with a high risk for OSAHS in the 
Berlin questionnaire constituting the dependent variable 
and multimorbidity being the main independent variable. 
Multimorbidity was examined both as a binary (yes/no) 
and as an ordinal variable (0–1, 2, and 3 or more chronic 
morbidities).
Because hypertension and obesity are accounted for 
when assessing the likelihood for OSAHS in the Ber-
lin questionnaire, we performed a sensitivity analysis by 
excluding these two conditions from the definition of 
multimorbidity. We also examined the persistence of our 
findings in the subgroup of subjects with EDS.
All reported P values were two-tailed, and a P value 
<0.05 was considered statistically significant. Data were 
analysed using IMB-SPSS version 22.
Ethics and consent
This study has a written ethical approval by the Scientific 
Council of the Department of Medicine at the University 
of Thessaly (Pr No 5740-7th/October 15, 2008). All study 
participants were advised about the voluntary nature of 
the study and gave informed consent.
Results
Study subjects
Of the 518 elderly adults solicited, 490 were interviewed 
and completed fully the study questionnaires (95  % 
response rate). Study participants had an average age 
of 77.5 ± 6.9 years (range, 65–98 years), and 51 % were 
male. None of the study subjects had a confirmed diagno-
sis for OSAHS prior to this study. Main characteristics of 
the study participants are presented in Table 1.
Prevalence of OSAHS and multimorbidity
Both the Berlin questionnaire and the ESS demonstrated 
good degrees of internal consistency (Cronbach’s alpha 
coefficient, 0.69 and 0.77, respectively). One-third of the 
study subjects (33.5 %, 95 % CI 29.4–37.8 %) were classi-
fied as being at a high risk of having OSAHS according 
to the Berlin questionnaire. Presence of EDS, as assessed 
by the ESS, was observed for 57 subjects (11.6 %, 95 % CI 
9.1–14.8 %).
The most prevalent chronic morbidities overall were 
hypertension, obesity, cardiovascular disease, diabetes 
mellitus and mental health disorder (Table 1). More than 
two-thirds of all study subjects had one or more chronic 
conditions, for an average number of 2.1 ± 1.4 morbidi-
ties. Defined as the presence of ≥2 chronic diseases, 
almost two-thirds of subjects were classified as having 
multimorbidity (63.9 %, 95 % CI 59.5–68.0 %). More than 
a third of patients had ≥3 chronic morbidities (35.7  %, 
95  % CI 31.6–40.1  %). Findings were similar across the 
different home care services and study locations.
Association between OSAHS and multimorbidity
A high pre-test likelihood for OSAHS was noted more 
frequently for study subjects who had a history of stroke, 
cardiovascular disease, diabetes mellitus or mental health 
Table 1 Main characteristics of the 490 study participants
CI confidence interval, OSAHS obstructive sleep apnoea–hypopnoea syndrome, 
EDS excessive daytime sleepiness
a Includes congestive heart failure, coronary artery disease and arrhythmias
b Includes anxiety, psychotic disorder and dementia
Characteristic n Prevalence (%) 95 % CI (%)
Male sex 248 50.6 46.2–55.0
Age (years)
 65–79 314 64.1 59.7–68.2
 ≥80 176 35.9 31.8–40.3
Smoking status
 Current 44 9.0 6.7–11.9
 Former 138 28.2 24.3–32.3
 Never 308 62.9 58.5–67.0
Most prevalent chronic morbidities
 Hypertension 257 52.4 48.0–56.9
 Obesity 217 44.3 39.9–48.7
 Cardiovascular diseasea 172 35.1 31.0–39.5
 Diabetes mellitus 117 23.9 20.3–27.9
 Mental health disorderb 61 12.4 9.8–15.7
 Stroke 24 4.9 3.3–7.2
 Depression 21 4.3 2.8–6.5
Number of chronic morbidities
 0–1 177 36.1 32.0–40.5
 2 138 28.2 24.3–32.3
 3 93 19.0 15.7–22.7
 ≥4 82 16.7 13.7–20.3
Screening assessment of sleep-related disorders
 Low pre-test risk for OSAHS 238 48.6 44.2–53.0
 High pre-test risk for OSAHS 164 33.5 29.4–37.8
 EDS 57 11.6 9.1–14.8
 EDS and high risk for OSAHS 42 8.6 6.4–11.4
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disorder, compared to those with no history of chronic 
disease (Table 2). Defined as the presence of ≥2 chronic 
diseases, multimorbidity showed a statistically significant 
association with a high pre-test likelihood for OSAH (OR 
3.67, 95 % CI 2.33–5.76).
When multimorbidity was treated as an ordinal vari-
able, a statistically significant dose–response association 
between the level of multimorbidity and a high pre-test 
likelihood for OSAHS was noted in patients with a his-
tory of two (OR 3.06, 95  % CI 1.81–5.15) and three or 
more (OR 4.22, 95  % CI 2.58–6.91) chronic diseases 
(χ2(1) = 33.34; P < 0.001 for linear trend). This associa-
tion persisted across different levels of risk for OSAHS in 
the Berlin questionnaire (Fig. 1) and remained unaltered 
after adjusting for potential confounding effects by age, 
sex and smoking status in a multiple logistic regression 
model (Table 2).
Subgroup and sensitivity analyses
The association between multimorbidity and high risk for 
OSAHS was more pronounced in the subgroup of the 57 
subjects who presented with EDS (adjusted OR 4.77, 95 % 
CI 1.33–17.18, P = 0.017) and retained a dose–response 
feature (adjusted OR 4.41, 95  % CI 1.05–18.49 for two 
morbidities; and adjusted OR 5.53, 95  % CI 0.91–33.45 
for three or more morbidities).
Following exclusion of hypertension and obesity from 
the definition of multimorbidity, the association between 
multimorbidity and high pre-test likelihood for OSAHS 
retained statistical significance, but was weaker (OR 1.54, 
95  % CI 1.04–2.29, P  =  0.033). When multimorbidity 
was treated as an ordinal variable, the observed dose–
response relationship also retained statistical significance 
(OR 1.46, 95  % CI 0.93–2.30 for two morbidities; OR 
1.72, 95  % CI 0.93–3.18 for three or more morbidities; 
χ2(1) = 4.37, P = 0.037 for linear trend).
Discussion
We assessed the risk of OSAHS, measured the prevalence 
of multimorbidity and explored the association between 
the two conditions in a cross-section of older adults in 
primary care settings. Our findings indicate that caring 
for elderly patients with sleep apnoea and those with 
multimorbidity are both common in primary care prac-
tice. Importantly, our analysis revealed a marked and 
persistent dose–response association between multimor-
bidity and a high risk for OSAHS, independently of age, 
sex and smoking status.
Table 2 Association between a high pre-test likelihood for OSAHS and main chronic morbidities and multimorbidity
OSAHS obstructive sleep apnoea–hypopnoea syndrome, OR odds ratio, CI confidence interval
a Table reports most prevalent morbidities
b Binary logistic regression
c Multiple logistic regression model adjusting for age, sex and smoking status
Chronic morbiditya Value Patients at high risk 
for OSAHS
Unadjusted effectb Adjusted effectc
N Prevalence,  % OR (95 % CI) P value Adjusted OR (95 % CI) P value
Hypertension No 45 19.3 1
Yes 119 46.3 3.60 (2.40–5.41) <0.001 3.77 (2.48–5.73) <0.001
Obesity No 62 22.7 1
Yes 102 47.0 3.02 (2.05–4.45) <0.001 3.08 (2.06–4.62) <0.001
Cardiovascular disease No 99 31.1 1
Yes 65 37.8 1.34 (0.91–1.98) 0.136 1.30 (0.87–1.94) 0.198
Diabetes mellitus No 119 31.9 1
Yes 45 38.5 1.33 (0.87–2.05) 0.190 1.29 (0.84–2.00) 0.249
Mental health disorder No 140 32.6 1
Yes 24 39.3 1.34 (0.77–2.33) 0.299 1.40 (0.80–2.45) 0.243
Stroke No 152 32.6 1
Yes 12 50.0 2.07 (0.91–4.71) 0.078 1.88 (0.82–4.31) 0.133
Depression No 158 33.7 1
Yes 6 28.6 0.79 (0.30–2.07) 0.627 0.84 (0.32–2.22) 0.723
Number of chronic morbidities 0–1 30 16.9 1
2 53 38.4 3.06 (1.81–5.15) 3.13 (1.85–5.30)
≥3 81 46.3 4.22 (2.58–6.91) <0.001 4.22 (2.55–6.96) <0.001
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Even though OSAHS is fairly common, it often remains 
largely undiagnosed in our populations (Young et  al. 
1993; Gibson 2004; Karachaliou et al. 2007). Likewise in 
this study, none of the study subjects had a prior diag-
nosis for OSAHS but the overall prevalence of subjects 
at high risk for OSAHS was 33.5  %, which is high and 
similar to the prevalence reported by previous studies in 
elderly populations (Sforza et al. 2011).
The prevalence of multimorbidity found in this study 
is also similar to that reported in epidemiologic studies 
of older adults in primary care settings around the world 
(Fortin et al. 2007, 2012). Multimorbidity is an emerging 
concept in the medical literature and research on its epi-
demiology and clinical importance is still in its infancy 
(Fortin et  al. 2007; Søndergaard et  al. 2015). Conse-
quently, only a limited number of studies have explored 
a potential link between the presence of multiple mor-
bidities and the occurrence of OSAHS (Smith et al. 2002; 
Foley et  al. 2004; Robichaud-Hallé et  al. 2012; Jennum 
et al. 2013).
The 2003 National Sleep Foundation ‘Sleep in America’ 
survey explored the association between the prevalence 
of self-reported sleep problems and chronic diseases and 
found that older adults (aged 55–84  years) with four or 
more medical conditions were more likely to have sleep 
problems (adjusted OR 1.62, 95  % CI 1.05–2.49) than 
those with no medical conditions (Foley et  al. 2004). 
More recently, Robichaud-Hallé et  al. (2012) recruited 
120 patients of various ages (30–75 years of age) who pre-
sented sleep apnoea of various severities as identified by 
polysomnography and reported that multimorbidity was 
associated with severe OSAHS (adjusted OR 7.33, 95  % 
CI 1.67–32.23). However, the composition of the sample 
in that study prevented the researches from assessing an 
exposure–response relationship between OSAHS and 
multimorbidity (Robichaud-Hallé et al. 2012).
In this study, we found a marked dose–response associ-
ation between multimorbidity and high risk for OSAHS, 
which was noted both in patients with two (adjusted 
OR 3.13, 95  % CI 1.85–5.30) and patients with three or 
more (adjusted OR 4.22, 95 % CI 2.55–6.96) chronic mor-
bidities and was more pronounced in patients with EDS 
(adjusted OR 4.77, 95  % CI 1.33–17.18). This associa-
tion persisted across different levels of OSAHS risk and 
was insensitive to varying definitions of multimorbidity. 
Therefore this study adds evidence to a pool of results 
which suggest that OSAHS is common in older adults 
and often coincides with their multimorbidity.
Compared to the general population, patients with 
OSAHS have been shown to use 23–50 % more resources 
(in terms of physician visits, physician fees and hospitali-
sations) in the five years prior to their diagnosis (Smith 
et  al. 2002). In a recent controlled study, Jennum et  al. 
(2013) used the National Patient Registry in Denmark 
to identify all patients diagnosed with sleep-disordered 
breathing in the country between 1986 and 2006 (over 
19,000 patients). They then showed that patients with 
OSAHS contacted the health care system for various 
health-related issues and had presented with a wide range 
of morbidities at least three years prior to their diagnosis 
of OSAHS. These included such well-known risk associa-
tions as obesity, diabetes and cardiovascular disease, but 
also lesser-known risk associations (Jennum et al. 2013).
As expected we found strong associations between a 
high pre-test likelihood for OSAHS and the presence 
of hypertension and obesity in our study subjects. High 
risk for OSAHS was also more prevalent in patients with 
stroke, cardiovascular disease and diabetes mellitus in 
our sample, but these differences were not statistically 
significant probably because our study was underpow-
ered to detect relatively small effect sizes. There are accu-
mulating evidences suggesting that OSAHS may be an 
independent risk factor for metabolic syndrome and car-
diovascular disorders (Vijayan 2012). However, many 
well-known risk factors for OSAHS, such as age, male 
sex, obesity, diabetes and hypertension are also known 
to increase the risk for cardiovascular disease and/or 
metabolic syndrome (Vijayan 2012). Similarly, a rela-
tion between OSAHS and stroke seems almost inevita-
ble given the association of OSAHS with hypertension. 
Fig. 1 The association between different levels of risk for obstruc-
tive sleep apnoea–hypopnoea syndrome (OSAHS) according to the 
Berlin questionnaire and the level of multimorbidity. Patients whose 
responses qualified as high risk in at least two sections of the Berlin 
questionnaire were assigned a high risk for OSAHS, those who quali-
fied in a single section of the questionnaire were assigned to a low 
risk for OSAHS, and those who did not qualify in any of the sections of 
the questionnaire were assigned to no risk for OSAHS. The vertical axis 
presents the prevalence of each level of multimorbidity within each 
level of OSAHS risk
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Establishing such cause-effect relationships with OSAHS 
is difficult, requires more data from intervention studies 
and randomized controlled trials and remains an active 
area of research.
It has been suggested that sleep-related symptoms such 
as snoring and excessive daytime sleepiness are associ-
ated with anxiety and depression (Bouscoulet et al. 2008). 
In our screening assessment, we found that patients 
with a history of depression or other mental health dis-
order were no more likely to present with a high-risk of 
OSAHS or EDS than were patients without depression. 
This is in agreement with a recent cross-sectional study 
on adults diagnosed with OSAHS at the sleep laboratory 
which did not find any evidence to indicate an independ-
ent association between the severity of sleep apnoea and 
the incidence of depression (Rezaeitalab et al. 2014).
This study has limitations that should be acknowledged. 
First, the cross-sectional nature of our study does not 
allow conclusions to be drawn regarding cause-effect rela-
tionships. Second, measurement error is possible in our 
assessment of multimorbidity because chronic morbidi-
ties were documented from medical files and we cannot 
exclude the possibility of undocumented or undiagnosed 
medical conditions. Third, performing a full sleep investi-
gation including overnight in-laboratory polysomnogra-
phy was not feasible in this large population-based study, 
as it is too costly, not possible for all study subjects, and 
portable equipment is unreliable. Instead we used two 
highly sensitive screening questionnaires to assess sleep 
apnoea, but these may be less specific for the diagnosis of 
OSAHS in older adults (Sforza et al. 2011). Therefore we 
cannot exclude the possibility that some subjects without 
sleep-disordered breathing may have been falsely classified 
as having a high risk for OSAHS in this study. Moreover, 
we don’t know whether central sleep apnoea or other types 
of sleep-disordered breathing might be present in our 
sample. It is difficult to assess the effect that such differen-
tial misclassifications might have had in our results; they 
might have given rise to falsely high or falsely low odds 
ratios in this study. Nevertheless, robustness of our find-
ings is supported by our sensitivity and subgroup analyses.
The present study adds to an emerging pool of infor-
mation regarding two newly developing areas of research, 
i.e. the epidemiology and clinical importance of OSAHS 
and those of multimorbidity. Comorbidity should be 
regarded as a patient characteristic that may affect the 
occurrence and relevant outcomes of another disease. 
Instead of focusing mainly on specific chronic diseases 
and their specific outcomes, this study points out that 
future research may need to consider OSAHS as an 
important co-morbidity in older adults.
This burden needs to be addressed with policies aim-
ing at improving the identification of undiagnosed 
OSAHS via population screening in primary care (Young 
et al. 2002). As snoring and sleepiness, the hallmarks of 
OSAHS, are highly prevalent in the general population, 
the challenge for primary care providers will lie in deter-
mining which patients with these symptoms warrant fur-
ther evaluations (Young et  al. 2002). The present study 
points out that practitioners caring for elderly patients 
who present with several, common and burdensome, 
chronic diseases should expect to find this multimor-
bidity often coinciding with undetected, and therefore 
untreated, OSAHS. If OSAHS is confirmed, it may affect 
the management of the patient who could benefit from 
treatments that are known to help control many associ-
ated chronic conditions (Robichaud-Hallé et al. 2012).
Multimorbidity may also be an important methodo-
logical issue in studies which assess the effects of new 
treatments or other interventions on clinical outcomes 
of elderly patients with OSAHS. Randomised controlled 
trials that exclude patients with multimorbidity may have 
severely limited external validity. Observational studies 
should adjust for potential confounding effects of multi-
morbidity on outcome variables in patients with OSAHS.
Conclusions
OSAHS is prevalent and largely undiagnosed in older 
adults and often coincides with multiple, common and 
burdensome, chronic diseases. This is a crucial incen-
tive to consider OSAHS as an important co-morbidity in 
older adults and systematically screen for OSAHS in pri-
mary care practice.
Authors’ contributions
Conception and design: CFK, EIK, ZD and KIG; data collection: CFK; data man-
agement and statistical analysis: EIK; writing of the manuscript: EIK and CFK; 
critically revising the manuscript for important intellectual content: GM, IVP 
and ZA; final approval of the manuscript: CFK, EIK, ZD, GM, IVP, ZA and KIG. All 
authors read and approved the final manuscript.
Author details
1 Department of Nursing, Technological Educational Institute of Crete, Herak-
lion, Greece. 2 School of Health and Related Research, University of Sheffield, 
Regent Court, 30 Regent Street, Sheffield S1 4DA, UK. 3 Department of Respira-
tory Medicine, University of Thessaly, Larissa, Greece. 4 Department of Nursing, 
Technological Educational Institute of Thessaly, Larissa, Greece. 
Competing interests
The authors declare that they have no competing interests.
Received: 10 October 2015   Accepted: 6 January 2016
References
Barnett K, Mercer SW, Norbury M et al (2012) Epidemiology of multimorbidity 
and implications for health care, research, and medical education: a cross-
sectional study. Lancet 380:37–43. doi:10.1016/S0140-6736(12)60240-2
Bouloukaki I, Komninos ID, Mermigkis C et al (2013) Translation and validation 
of Berlin questionnaire in primary health care in Greece. BMC Pulm Med 
13:6. doi:10.1186/1471-2466-13-6
Page 7 of 7Kleisiaris et al. SpringerPlus  (2016) 5:34 
Bouscoulet LT, Vázquez-García JC, Muiño A et al (2008) Prevalence of sleep 
related symptoms in four Latin American cities. J Clin Sleep Med 
4:579–585
Dorasamy P (2007) Obstructive sleep apnea and cardiovascular risk. Ther Clin 
Risk Manag 3:1105–1111
Epstein LJ, Kristo D, Strollo PJ et al (2009) Clinical guideline for the evaluation, 
management and long-term care of obstructive sleep apnea in adults. J 
Clin Sleep Med 5:263–276
Foley D, Ancoli-Israel S, Britz P, Walsh J (2004) Sleep disturbances and chronic 
disease in older adults: results of the 2003 National Sleep Foundation 
Sleep in America Survey. J Psychosom Res 56:497–502. doi:10.1016/j.
jpsychores.2004.02.010
Fortin M, Soubhi H, Hudon C et al (2007) Multimorbidity’s many challenges. 
BMJ 334:1016–1017. doi:10.1136/bmj.39201.463819.2C
Fortin M, Stewart M, Poitras M-E et al (2012) A systematic review of prevalence 
studies on multimorbidity: toward a more uniform methodology. Ann 
Fam Med 10:142–151. doi:10.1370/afm.1337
Gibson GJ (2004) Obstructive sleep apnoea syndrome: underestimated and 
undertreated. Br Med Bull 72:49–65. doi:10.1093/bmb/ldh044
Jennum P, Ibsen R, Kjellberg J (2013) Morbidity prior to a diagnosis of sleep-
disordered breathing: a controlled national study. J Clin Sleep Med 
9:103–108. doi:10.5664/jcsm.2398
Johns MW (1991) A new method for measuring daytime sleepiness: the 
Epworth sleepiness scale. Sleep 14:540–545
Karachaliou F, Kostikas K, Pastaka C et al (2007) Prevalence of sleep-related 
symptoms in a primary care population—their relation to asthma and 
COPD. Prim Care Respir J 16:222–228. doi:10.3132/pcrj.2007.00045
Kleisiaris CF, Kritsotakis EI, Daniil Z et al (2014) The prevalence of obstructive 
sleep apnea-hypopnea syndrome-related symptoms and their relation 
to airflow limitation in an elderly population receiving home care. Int J 
Chron Obstruct Pulmon Dis 9:1111–1117. doi:10.2147/COPD.S67779
Minas M, Koukosias N, Zintzaras E et al (2010) Prevalence of chronic diseases 
and morbidity in primary health care in central Greece: an epidemiologi-
cal study. BMC Health Serv Res 10:252. doi:10.1186/1472-6963-10-252
Netzer NC, Stoohs RA, Netzer CM et al (1999) Using the Berlin Questionnaire 
to identify patients at risk for the sleep apnea syndrome. Ann Intern Med 
131:485–491
Ornstein SM, Nietert PJ, Jenkins RG, Litvin CB (2013) The prevalence of chronic 
diseases and multimorbidity in primary care practice: a PPRNet report. J 
Am Board Fam Med 26:518–524. doi:10.3122/jabfm.2013.05.130012
Parish JM, Adam T, Facchiano L (2007) Relationship of metabolic syndrome 
and obstructive sleep apnea. J Clin Sleep Med 3:467–472
Rezaeitalab F, Moharrari F, Saberi S et al (2014) The correlation of anxiety 
and depression with obstructive sleep apnea syndrome. J Res Med Sci 
19:205–210
Robichaud-Hallé L, Beaudry M, Fortin M (2012) Obstructive sleep apnea and 
multimorbidity. BMC Pulm Med 12:60. doi:10.1186/1471-2466-12-60
Sforza E, Chouchou F, Pichot V et al (2011) Is the Berlin questionnaire a useful 
tool to diagnose obstructive sleep apnea in the elderly? Sleep Med 
12:142–146. doi:10.1016/j.sleep.2010.09.004
Skaperdas I, Lavdaniti M, Dimitriadou A et al (2010) Satisfaction from the “Help 
at Home” programme in a prefecture of central Greece. Int J Nurs Pract 
16:342–351. doi:10.1111/j.1440-172X.2010.01850.x
Smith R, Ronald J, Delaive K et al (2002) What are obstructive sleep apnea 
patients being treated for prior to this diagnosis? Chest 121:164–172
Søndergaard E, Willadsen TG, Guassora AD et al (2015) Problems and chal-
lenges in relation to the treatment of patients with multimorbidity: 
general practitioners’ views and attitudes*. Scand J Prim Health Care. doi:
10.3109/02813432.2015.1041828
Tsara V, Serasli E, Amfilochiou A et al (2004) Greek version of the Epworth 
Sleepiness Scale. Sleep Breath 8:91–95. doi:10.1007/s11325-004-0091-6
Vijayan VK (2012) Morbidities associated with obstructive sleep apnea. Expert 
Rev Respir Med 6:557–566. doi:10.1586/ers.12.44
Young T, Palta M, Dempsey J et al (1993) The occurrence of sleep-disordered 
breathing among middle-aged adults. N Engl J Med 328:1230–1235. 
doi:10.1056/NEJM199304293281704
Young T, Peppard PE, Gottlieb DJ (2002) Epidemiology of obstructive sleep 
apnea: a population health perspective. Am J Respir Crit Care Med 
165:1217–1239
